AHA Coding Clinic® for ICD-9 - 2008 Issue 4; VOLUMES 1 AND 2 NEW/REVISED CODES
Malignant Neoplasm of Transplanted Organ
Effective October 1, 2008, code 199.2, Malignant neoplasm associated with transplanted organ, has been created for transplant related malignancies. There are several ways in which a transplanted organ may develop cancer, such as: The recipient may have a past history of cancer that recurs and spreads to the transplanted organ The transplanted organ may have undetected malignant cells prior to the transplant surgery; or Cancer may develop when the immune system is weakened due to the usage of immunosuppressant drug therapy that is necessary to avoid allograft rejection. 199 Malignant neoplasm without specification of site Add Excludes: malignant...
Subscribe or sign in to view the full article.
Article Overview
This premium article focuses on a diagnosis update for malignancy associated with transplanted organs and places it in the context of transplant complications, cancer history, and immunosuppression-related cancer risk. It is intended for coders and billing professionals who need to understand the scope of the update, the related diagnosis categories, and the type of coding guidance illustrated by the article’s example admission.
Why This Topic Matters
Transplant-related malignancy coding can involve more than one diagnosis category, and this article helps readers understand the broader context of when the new diagnosis category applies and what other related diagnoses may be discussed alongside it. It is relevant for accurate medical record abstraction, claim preparation, and staying aligned with the effective-date update described in the source.
Article Sections
-
Effective October 1, 2008 update
Introduces the diagnosis update and places it within the broader topic of malignancy associated with transplanted organs. The section frames the article around the newly created diagnosis category and its transplant-related context.
-
Ways a transplanted organ may develop cancer
Summarizes the broad clinical scenarios discussed in the article for how transplant-related malignancy may arise. The section addresses recurrence, preexisting malignant cells, and immune suppression as general themes.
-
Coding guidance and example admission
Presents the related diagnosis category, associated transplant complication context, and a sample admission involving chemotherapy. The section also indicates that the article includes code assignment guidance tied to the example.
What You Will Learn
- The scope of a transplant-related malignancy diagnosis update
- How the topic is connected to transplant complications and specific malignancy sites
- What kinds of clinical scenarios are discussed in relation to cancer in a transplanted organ
- How the article frames a sample admission involving chemotherapy and transplant-related diagnoses
Who Should Read This
- Medical coders
- Coding auditors
- Billing and reimbursement staff
- Health information management professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com